0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Special Feature |  FREE
Cynthia J. Burk, MD; Bharani Pandrangi, MD; Elizabeth Alvarez Connelly, MD
Arch Pediatr Adolesc Med. 2008;162(3):277. doi:10.1001/archpediatrics.2007.61-a.

Article |  FREE
Katherine Ayers, BA; Susan M. Sweeney, MD; Karen Wiss, MD
Arch Pediatr Adolesc Med. 2005;159(1):64-67. doi:10.1001/archpedi.159.1.64.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Viewpoint  | 
Transgender Patients, Isotretinoin, and US Food and Drug Administration–Mandated Risk Evaluation and Mitigation Strategies A Prescription for Inclusion
Kenneth A. Katz, MD, MSc, MSCE
JAMA Dermatology
Editorial  | 
Isotretinoin Laboratory Test Monitoring—A Call to Decrease Testing in an Era of High-Value, Cost-Conscious Care
Kanade Shinkai, MD, PhD; Amy McMichael, MD; Eleni Linos, MD, MPH, DrPH
JAMA Dermatology
Original Investigation  | 
Laboratory Monitoring During Isotretinoin Therapy for Acne A Systematic Review and Meta-analysis
Young H. Lee, MD; Thomas P. Scharnitz, BS; Joshua Muscat, PhD; et al.
JAMA Dermatology
Editorial  | 
Reevaluating the Need for Laboratory Testing in the Treatment of Onychomycosis Safety and Cost-effectiveness Considerations
Matthew H. Kanzler, MD